日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trained mesenchymal stromal cell-based therapy HXB-319 for treating diffuse alveolar hemorrhage in a pristane-induced murine model.

训练有素的间充质基质细胞疗法 HXB-319 用于治疗普瑞斯坦诱导的小鼠模型中的弥漫性肺泡出血

Bukulmez Hulya, Dennis Adrienne T, Reese-Koc Jane, Sieg Scott F, Clagett Brian, Kleinsorge-Block Sarah, Somoza-Palacios Rodrigo, Singer Nora, Chance Mark, Highland Kristin B, Emancipator Steven N

Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells

T调节细胞辅助治疗可减轻炎症并保持CAR-T细胞的抗肿瘤活性

Zeng, Ke; Huang, Meixian; Lyu, Mi-Ae; Khoury, Joseph D; Ahmed, Sairah; Patel, Krina K; Dropulić, Boro; Reese-Koc, Jane; Caimi, Paolo F; Sadeghi, Tara; Lima, Marcos de; Flowers, Christopher R; Parmar, Simrit

A Phase I Study to Determine the Maximum Tolerated Dose of ex Vivo Expanded Natural Killer Cells Derived from Unrelated, HLA-Disparate Adult Donors

一项I期研究旨在确定来自无关、HLA不匹配的成年供体的体外扩增自然杀伤细胞的最大耐受剂量

Otegbeye, Folashade; Cooper, Brenda; Caimi, Paolo; Zamborsky, Kayla; Reese-Koc, Jane; Hillian, Antoinette; Hernandez-Collazo, Yeritza; Lee, Grace; Boughan, Kirsten; Tomlinson, Benjamin; Gallogly, Molly; Metheny, Leland; Bajor, David; Selfridge, Jennifer; Saltzman, Joel; Lazarus, Hillard; de Lima, Marcos; Wald, David

Optimization of Human Mesenchymal Stem Cells for Rheumatoid Arthritis: Implications for Improved Therapeutic Outcomes

人类间充质干细胞治疗类风湿关节炎的优化:对改善治疗效果的意义

Maya Breitman, Tracey L Bonfield, Arnold I Caplan, Hillard M Lazarus, Maricela Haghiac, Susan LaSalvia, Jane Reese-Koc, Nora G Singer

Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients

多中心院内生产的抗CD19 CAR-T细胞可使B细胞恶性肿瘤患者获得较高的缓解率。

Maschan, Michael; Caimi, Paolo F; Reese-Koc, Jane; Sanchez, Gabriela Pacheco; Sharma, Ashish A; Molostova, Olga; Shelikhova, Larisa; Pershin, Dmitriy; Stepanov, Alexey; Muzalevskii, Yakov; Suzart, Vinicius G; Otegbeye, Folashade; Wald, David; Xiong, Ying; Wu, Darong; Knight, Adam; Oparaocha, Ibe; Ferencz, Beatrix; Roy, Andre; Worden, Andrew; Kruger, Winfried; Kadan, Michael; Schneider, Dina; Orentas, Rimas; Sekaly, Rafick-Pierre; de Lima, Marcos; Dropulić, Boro

Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma

非霍奇金淋巴瘤抗CD19 CAR-T细胞疗法前预防性使用托珠单抗

Caimi, Paolo F; Pacheco Sanchez, Gabriela; Sharma, Ashish; Otegbeye, Folashade; Ahmed, Nausheen; Rojas, Patricio; Patel, Seema; Kleinsorge Block, Sarah; Schiavone, Jennifer; Zamborsky, Kayla; Boughan, Kirsten; Hillian, Antoinette; Reese-Koc, Jane; Maschan, Mikhail; Dropulic, Boro; Sekaly, Rafick-Pierre; de Lima, Marcos

Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria

对于包括符合 mSMART 标准的患者在内的多发性骨髓瘤患者,储存的外周血干细胞用于自体挽救性移植的成本高昂且利用率低。

Ahmed, Nausheen; Li, Lucy; Rojas, Patricio; Covut, Fahrettin; Reese-Koc, Jane; Kolk, Merle; Malek, Ehsan; Metheny, Leland; O'Brien, Timothy; Caimi, Paolo; de Lima, Marcos; Cooper, Brenda W

Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis.

多发性硬化症静脉自体培养扩增间充质干细胞移植的试点试验

Cohen Jeffrey A, Imrey Peter B, Planchon Sarah M, Bermel Robert A, Fisher Elizabeth, Fox Robert J, Bar-Or Amit, Sharp Susan L, Skaramagas Thomai T, Jagodnik Patricia, Karafa Matt, Morrison Shannon, Reese Koc Jane, Gerson Stanton L, Lazarus Hillard M